Nd3+-Doped LiLuF4 Nanoparticles for Near-Infrared/Computed Tomography Dual-Mode Imaging
Source abstract
Abstract
Nd 3+ ions are commonly employed as sensitizers in lanthanide luminescent nanoprobes. However, the cross-relaxation effect typically limits their doping concentration to less than 5%. To address this limitation, we synthesized and manipulated LiLuF 4:Yb,Nd nanoparticles through a rational design of the host lattice and optimization of the doping concentration, achieving up to a 50% doped Nd 3+ concentration. The nanoparticles’ morphology, energy transfer mechanisms, and luminescent properties revealed robust near-infrared luminescence and successful imaging of mouse blood vessels. Furthermore, the inclusion of Lu in the nanoparticles enabled X-ray computed tomography imaging, enabling dual-modal imaging capabilities. This study presents a strategy for enhancing the performance of lanthanide luminescent nanoprobes and expanding their applications in multimodal imaging.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Luminescence Properties of Advanced Materials · Atomic and Subatomic Physics Research · Medical Imaging Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Materials Science & Engineering & Institute of Smart Biomedical Materials and Zhejiang-Mauritius Joint Research Center for Biomaterials and Tissue Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, P.R. China
Funding
National Natural Science Foundation of China · Natural Science Foundation of Zhejiang Province
References (46)
Show source-provided references
1. 10.1016/j.ccr.2022.21472410.1016/j.ccr.2022.214724 ↗
2. 10.1039/D3QI00184A10.1039/D3QI00184A ↗
3. 10.1039/D2TC00627H10.1039/D2TC00627H ↗
4. 10.1016/j.cej.2022.13844010.1016/j.cej.2022.138440 ↗
5. 10.1016/j.ccr.2018.03.00710.1016/j.ccr.2018.03.007 ↗
6. 10.1016/j.ccr.2021.21397110.1016/j.ccr.2021.213971 ↗
7. 10.1016/j.ccr.2018.11.01410.1016/j.ccr.2018.11.014 ↗
8. 10.1021/ar300150c10.1021/ar300150c ↗
9. 10.1021/nn405082y10.1021/nn405082y ↗
10. 10.1126/sciadv.abo328910.1126/sciadv.abo3289 ↗
11. 10.1016/j.apmt.2018.11.01110.1016/j.apmt.2018.11.011 ↗
12. 10.1155/2016/103925810.1155/2016/1039258 ↗
13. 10.1002/adfm.20210100510.1002/adfm.202101005 ↗
14. 10.1039/C8NR00446C10.1039/C8NR00446C ↗
15. 10.1016/j.cplett.2013.12.02210.1016/j.cplett.2013.12.022 ↗
16. 10.1364/JOSAB.20.00197510.1364/JOSAB.20.001975 ↗
17. 10.1021/nn402601d10.1021/nn402601d ↗
18. 10.1021/acs.inorgchem.6b0153610.1021/acs.inorgchem.6b01536 ↗
19. 10.1021/acs.chemmater.8b0405710.1021/acs.chemmater.8b04057 ↗
20. 10.1021/acsnano.7b0918910.1021/acsnano.7b09189 ↗
21. 10.1021/acsami.7b0430510.1021/acsami.7b04305 ↗
22. 10.1039/C9NR02801C10.1039/C9NR02801C ↗
23. 10.1002/anie.20130950310.1002/anie.201309503 ↗
24. 10.1039/C5TC01438G10.1039/C5TC01438G ↗
25. 10.1021/jacs.7b0022310.1021/jacs.7b00223 ↗
26. 10.1021/acs.chemrev.2c0041910.1021/acs.chemrev.2c00419 ↗
27. 10.1002/smll.20220695610.1002/smll.202206956 ↗
28. 10.1002/adfm.20230168310.1002/adfm.202301683 ↗
29. 10.1134/S106377611302013110.1134/S1063776113020131 ↗
30. 10.1039/D1RA08989G10.1039/D1RA08989G ↗
31. 10.1002/zaac.20220009010.1002/zaac.202200090 ↗
32. 10.1021/acs.nanolett.5b0283010.1021/acs.nanolett.5b02830 ↗
33. 10.1039/C7NR02594G10.1039/C7NR02594G ↗
34. 10.1039/C8NR00871J10.1039/C8NR00871J ↗
35. 10.1021/ja207078s10.1021/ja207078s ↗
36. 10.1039/C5NR04889C10.1039/C5NR04889C ↗
37. 10.1021/acs.inorgchem.9b0107110.1021/acs.inorgchem.9b01071 ↗
38. 10.1021/ja407500210.1021/ja4075002 ↗
39. 10.1007/s12274-014-0549-110.1007/s12274-014-0549-1 ↗
40. 10.1039/C5TB02023A10.1039/C5TB02023A ↗
41. 10.1021/nn304373q10.1021/nn304373q ↗
42. 10.1002/adfm.20170736510.1002/adfm.201707365 ↗
43. 10.1016/j.jconrel.2022.09.03110.1016/j.jconrel.2022.09.031 ↗
44. 10.1016/j.biomaterials.2015.06.02310.1016/j.biomaterials.2015.06.023 ↗
45. 10.1016/j.biomaterials.2013.11.08210.1016/j.biomaterials.2013.11.082 ↗
46. 10.1002/adfm.20150367210.1002/adfm.201503672 ↗